$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

$hdsn Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000114420418027130 Filed on May 10, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$42.43M	$38.83M
YoY Change	9.27%	37.86%
Cost Of Revenue	$34.52M	$26.36M
YoY Change	30.95%	27.7%
Gross Profit	$7.905M	$12.47M
YoY Change	-36.59%	65.74%
Gross Profit Margin	18.63%	32.11%
Selling, General & Admin	$8.077M	$2.952M
YoY Change	173.61%	17.94%
% of Gross Profit	102.18%	23.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.012M	$483.0K
YoY Change	109.52%	-20.3%
% of Gross Profit	12.8%	3.87%
Operating Expenses	$8.819M	$3.074M
YoY Change	186.89%	22.81%
Operating Profit	-$914.0K	$9.393M
YoY Change	-109.73%	87.15%
Interest Expense	$3.206M	$85.00K
YoY Change	3671.76%	-131.48%
% of Operating Profit		0.9%
Other Income/Expense, Net	-$3.206M	-$85.00K
YoY Change	3671.76%	-68.63%
Pretax Income	-$4.120M	$9.308M
YoY Change	-144.26%	96.04%
Income Tax	-$1.064M	$3.574M
% Of Pretax Income		38.4%
Net Earnings	-$3.056M	$5.734M
YoY Change	-153.3%	94.77%
Net Earnings / Revenue	-7.2%	14.77%
Basic Earnings Per Share	-$0.07	$0.14
Diluted Earnings Per Share	-$0.07	$0.13
COMMON SHARES
Basic Shares Outstanding	42.40M	41.51M
Diluted Shares Outstanding	42.40M	43.50M

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.000M	$40.20M
YoY Change	-97.51%	3250.0%
Cash & Equivalents	$978.0K	$40.16M
Short-Term Investments
Other Short-Term Assets	$3.900M	$6.300M
YoY Change	-38.1%	53.66%
Inventory	$170.9M	$72.40M
Prepaid Expenses
Receivables	$26.90M	$20.70M
Other Receivables	$9.600M	$0.00
Total Short-Term Assets	$212.3M	$139.5M
YoY Change	52.21%	82.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.66M	$7.400M
YoY Change	300.74%	2.78%
Goodwill	$49.46M
YoY Change
Intangibles	$31.68M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$184.0K	$2.100M
YoY Change	-91.24%	31.25%
Total Long-Term Assets	$111.0M	$13.60M
YoY Change	716.03%	2.26%
TOTAL ASSETS
Total Short-Term Assets	$212.3M	$139.5M
Total Long-Term Assets	$111.0M	$13.60M
Total Assets	$323.3M	$153.1M
YoY Change	111.18%	70.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$29.20M	$29.00M
YoY Change	0.69%	663.16%
Accrued Expenses	$19.10M	$2.400M
YoY Change	695.83%	-17.24%
Deferred Revenue
YoY Change
Short-Term Debt	$52.10M	$0.00
YoY Change
Long-Term Debt Due	$1.050M	$100.0K
YoY Change	950.0%	-99.62%
Total Short-Term Liabilities	$101.5M	$34.96M
YoY Change	190.23%	6.26%
LONG-TERM LIABILITIES
Long-Term Debt	$101.0M	$129.0K
YoY Change	78191.47%	-96.93%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$101.0M	$129.0K
YoY Change	78191.47%	-96.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$101.5M	$34.96M
Total Long-Term Liabilities	$101.0M	$129.0K
Total Liabilities	$202.9M	$35.09M
YoY Change	478.16%	-5.42%
SHAREHOLDERS EQUITY
Retained Earnings	$5.670M	$3.304M
YoY Change	71.61%	-132.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$120.4M	$118.0M
YoY Change
Total Liabilities & Shareholders Equity	$323.3M	$153.1M
YoY Change	111.16%	70.63%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$3.056M	$5.734M
YoY Change	-153.3%	94.77%
Depreciation, Depletion And Amortization	$1.012M	$483.0K
YoY Change	109.52%	-20.3%
Cash From Operating Activities	$9.503M	$6.943M
YoY Change	36.87%	-221.38%
INVESTING ACTIVITIES
Capital Expenditures	$206.0K	$369.0K
YoY Change	-44.17%	177.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$206.0K	-$369.0K
YoY Change	-44.17%	183.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$17.00K	$267.0K
YoY Change	-93.63%	-3.96%
Debt Paid & Issued, Net	$263.0K	$85.00K
YoY Change	209.41%	-8.6%
Cash From Financing Activities	-13.32M	-$346.0K
YoY Change	3750.0%	-106.0%
NET CHANGE
Cash From Operating Activities	9.503M	$6.943M
Cash From Investing Activities	-206.0K	-$369.0K
Cash From Financing Activities	-13.32M	-$346.0K
Net Change In Cash	-4.024M	$6.228M
YoY Change	-164.61%	-7885.0%
FREE CASH FLOW
Cash From Operating Activities	$9.503M	$6.943M
Capital Expenditures	$206.0K	$369.0K
Free Cash Flow	$9.297M	$6.574M
YoY Change	41.42%	-212.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	101466000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	95360000	USD
CY2018Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	410000	USD
CY2018Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	100996000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1473000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5670000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8727000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	101158000	USD
CY2018Q1	us-gaap	Assets Assets	323311000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30461000	USD
CY2017Q4	us-gaap	Assets Assets	321444000	USD
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31677000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	202872000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	197991000	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	123453000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321444000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	424000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	10885000	USD
CY2018Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	9664000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	49464000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	208916000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	184000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3904000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6934000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	212331000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29655000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	49464000	USD
CY2017Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	9664000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	114345000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	114302000	USD
CY2018Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1050000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1050000	USD
CY2018Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	52098000	USD
CY2017Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	65152000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34523000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-914000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	3206000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-3056000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42403029	shares
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42403029	shares
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3206000	USD
CY2017Q1	us-gaap	Revenues Revenues	38830000	USD
CY2017Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26363000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9393000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32419000	USD
CY2017Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	15221000	USD
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2659000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3052000	USD
CY2018Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	16411000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	7905000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	8819000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	16000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4024000	USD
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41507941	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43503889	shares
CY2017Q1	us-gaap	Gross Profit GrossProfit	12467000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	3074000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	85000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-85000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8077000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2952000	USD
CY2018Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	742000	USD
CY2017Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	122000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	241000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1064000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12026000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-472000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2911000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	19160000	USD
CY2018Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	263000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	483000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	307000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15964000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3751000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5471000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	22171000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	85000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6228000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40159000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	3266000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33931000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	742000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122000	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	1080000	USD
CY2017Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2018Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2017Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	528000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9503000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6943000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-206000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-369000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-13321000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-346000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	2930000	USD
CY2017Q1	us-gaap	Interest Paid Net InterestPaidNet	89000	USD
CY2017Q4	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	209000000	USD
CY2018Q1	us-gaap	Payables To Customers PayablesToCustomers	10300000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35	pure
CY2017Q4	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1400000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	1000000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	500000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49920000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	32419000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	27000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6000000	shares
CY2018Q1	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	2374722	shares
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49714000	USD
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20265000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3200000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19253000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34913000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34913000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3236000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2494000	USD
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31677000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5500000	USD
CY2018Q1	hdsn	Capital Lease Obligations Repayments Interest Included In Payments CapitalLeaseObligationsRepaymentsInterestIncludedInPayments	6000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	1147000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	3210000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	1079000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	1057000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	1052000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	104873000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	1050000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	10114000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	208969000	USD
CY2018Q1	hdsn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested	0	USD
CY2018Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	52098000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	65152000	USD
CY2018Q1	us-gaap	Debt Current DebtCurrent	53148000	USD
CY2017Q4	us-gaap	Debt Current DebtCurrent	66202000	USD
CY2018Q1	hdsn	Vehicle And Equipment Loans VehicleAndEquipmentLoans	22000	USD
CY2017Q4	hdsn	Vehicle And Equipment Loans VehicleAndEquipmentLoans	39000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	20000	USD
CY2018Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	16000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2851000	USD
CY2018Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2730000	USD
CY2018Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	103688000	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	103950000	USD
CY2018Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	154144000	USD
CY2017Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	167360000	USD
CY2018Q1	hdsn	Longterm Debt Current Net Of Other Debt LongtermDebtCurrentNetOfOtherDebt	1050000	USD
CY2017Q4	hdsn	Longterm Debt Current Net Of Other Debt LongtermDebtCurrentNetOfOtherDebt	1050000	USD
CY2018Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	57000000	USD
CY2018Q1	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	100000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	86000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	15000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	6000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	2000	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2018Q1	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	103000	USD
CY2018Q1	hdsn	Capital Lease Obligations Repayments Due CapitalLeaseObligationsRepaymentsDue	109000	USD
CY2018Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive	99488000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	14668000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	734000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	103876000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	24179000	USD
CY2017Q4	hdsn	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Customer Relationships BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCustomerRelationships	29660000	USD
CY2017Q4	hdsn	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Above Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAboveMarketLeases	567000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	48609000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	222293000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	13324000	USD
CY2018Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	48600000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42403140	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42403140	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	42398140	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	42398140	shares
CY2018Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Credit Risk</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the three-month period ended March 31, 2018, there was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">one customer accounting for 11% of the Company’s revenues</font>. At March 31, 2018 there was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.0</font> million of accounts receivable from this customer.</div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the three-month period ended March 31, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">two customers each accounted for 10% or more of the Company’s revenues</font> and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 39</font>% of the Company’s revenues. At March 31, 2017, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.1</font> million in outstanding receivables from these customers. </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Estimates and Risks</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Several of the Company’s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, valuation allowances for deferred tax assets, and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and productionof all virgin HCFC refrigerants is scheduled to be phased out by 2030. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the “Final Rule”). In the Final Rule, the EPA established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year and ending at zero in 2020.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	41101000	USD
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	37670000	USD
CY2018Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1327000	USD
CY2017Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1160000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1995948	shares
CY2017Q1	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two customers each accounted for 10% or more of the Companys revenues
CY2017Q4	us-gaap	Payables To Customers PayablesToCustomers	9800000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2948848	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2948848	shares
CY2018Q1	hdsn	Production And Importation Permission Description ProductionAndImportationPermissionDescription	22 million pounds in 2015 and was reduced by approximately 4.5 million pounds each year and ending at zero in 2020.
CY2018Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1991-01-11
CY2017Q1	hdsn	Earnings Before Interest Tax Depreciation And Amortization EarningsBeforeInterestTaxDepreciationAndAmortization	21900000	USD
CY2017Q2	hdsn	Earnings Before Interest Tax Depreciation And Amortization EarningsBeforeInterestTaxDepreciationAndAmortization	26100000	USD
CY2017	hdsn	Fixed Charges Coverage Ratio FixedChargesCoverageRatio	6.47 to 1
CY2018Q1	hdsn	Fixed Charge Coverage Ratio Requirement FixedChargeCoverageRatioRequirement	1.00 to 1.00
CY2018Q1	hdsn	Ratios Of Indebtedness To Net Capital Requirement RatiosOfIndebtednessToNetCapitalRequirement	4.75 to 1.00
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2840848	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.14
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y1M20D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	20000	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2017Q4	hdsn	Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested	0	USD
CY2018Q1	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1	13950	USD
CY2017Q4	hdsn	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable And Vested Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAndVestedIntrinsicValue1	260747	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	206000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	369000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	267000	USD
CY2018Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	-13075000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	0	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2018Q1	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	one customer accounting for 11% of the Companys revenues
CY2018Q1	hdsn	Fixed Charges Coverage Ratio FixedChargesCoverageRatio	3.31 to 1
CY2018Q1	hdsn	Ratios Of Indebtedness To Net Capital RatiosOfIndebtednessToNetCapital	4.23 to 1
CY2017	hdsn	Ratios Of Indebtedness To Net Capital RatiosOfIndebtednessToNetCapital	3.03 to 1
CY2018Q1	us-gaap	Fees And Commissions FeesAndCommissions	600000	USD
CY2017Q1	us-gaap	Fees And Commissions FeesAndCommissions	600000	USD
CY2018Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5400000	USD
CY2018Q1	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	$4.1 million of which are subject to annual limitations of approximately $1.3 million.
CY2018Q1	hdsn	Operating Loss Carry Forwards Expirations Date OperatingLossCarryForwardsExpirationsDate	2024

Files In Submission

Name	View Source	Status
0001144204-18-027130-index-headers.html	Edgar Link	pending
0001144204-18-027130-index.html	Edgar Link	pending
0001144204-18-027130.txt	Edgar Link	pending
0001144204-18-027130-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hdsn-20180331.xml	Edgar Link	completed
hdsn-20180331.xsd	Edgar Link	pending
hdsn-20180331_cal.xml	Edgar Link	unprocessable
hdsn-20180331_def.xml	Edgar Link	unprocessable
hdsn-20180331_lab.xml	Edgar Link	unprocessable
hdsn-20180331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tv493231_10q.htm	Edgar Link	pending
tv493231_ex31-1.htm	Edgar Link	pending
tv493231_ex31-2.htm	Edgar Link	pending
tv493231_ex32-1.htm	Edgar Link	pending
tv493231_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2018 Q1 Form 10-Q Financial Statement

#000114420418027130 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2018 Q1 Form 10-Q Financial Statement

#000114420418027130 Filed on May 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn